# Phase 2 Trial of Lisocabtagene Maraleucel for Minimal Residual Disease in Patients With Large B-cell Lymphoma

> clinical trial · VERIFIED · 2026-06-30

Status: RECRUITING · Sponsor: M.D. Anderson Cancer Center · Condition: Large B-cell Lymphoma

- Company: M.D. Anderson Cancer Center
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07316010

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.